• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “Opioids Agonist Drugs Market – 2019-2024” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the global and regional/market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current Product Type and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the Opioids Agonist Drugs Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in Opioids Agonist Drugs Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Opioids Agonist Drugs Market Size & Forecast:

Global Opioids Agonist Drugs market witnessed a market value of USD XX Million in 2019 and is estimated to reach USD XX million in 2024, registering a compound annual growth rate (CAGR) of XX% between 2019 and 2024. The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Opioids Agonist Drugs Market Segmentation:-
The research offers a comprehensive analysis of global Opioids Agonist Drugs market with respect to following sub-markets:

Based on Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone

Based on Therapeutic Application:
- Pain Management
- - - Neuropathic Pain
- - - Migraine
- - - Back Pain
- - - Osteoarthritis Pain
- - - Cancer Pain
- - - Others
- Cough Treatment
- Diarrhea Treatment

Global Opioids Agonist Drugs Market: Competitive Landscape

The report also highlights the competitive landscape of the global Opioids Agonist Drugs market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Technology development, research & development and other market activities).

The report includes profiles of leading companies in the global Opioids Agonist Drugs market.

Some of the key players profiled include:

- Purdue Pharma
- Titan pharmaceuticals
- Boehringer Ingelheim
- Janssen Pharmaceuticals, Inc.
- Sanofi
- Sun Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Egalet Corporation
- Endo Pharmaceuticals Inc.
- Allergan, Plc
- Pfizer Inc.
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2015 to 2017 – Historical Year
- 2018 – Base Year
- 2019 – Estimated Year
- 2019 to 2024 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Opioids Agonist Drugs Industry Report;

- What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Preface

1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process and Design
1.1.2.1. Secondary Research
1.1.2.2. Key Sources and Use of Primary Research
1.1.2.3. Market Size Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of the Study
1.5. Assumptions and Limitations for Market Estimation and Forecasting

2. Executive Summary

2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top Global Opioids Agonist Drugs Market Trends for 2019

3. Porter’s Five Force Analysis

3.1. Threat of Substitutes
3.2. Bargaining Power of Buyers
3.3. Bargaining Power of Suppliers
3.4. Threat of New Entrants
3.5. Degree of Competition

4. Manufacturing Cost Structure Analysis

4.1. Raw Material and Suppliers
4.2. Industry Chain Structure of Opioids Agonist Drugs
4.3. Manufacturing Process Analysis of Opioids Agonist Drugs
4.4. Manufacturing Cost Structure Analysis of Opioids Agonist Drugs

5. Manufacturing Plants Analysis of Opioids Agonist Drugs

5.1. Capacity and Production
5.2. Global Opioids Agonist Drugs Manufacturing Plants Distribution
5.3. Recent Development and Expansion Plans

6. Competitive Landscape

6.1. Global Opioids Agonist Drugs Market 2018
6.2. Global Opioids Agonist Drugs Market Value Share, By Company 2018
6.3. Global Opioids Agonist Drugs Market Volume Share, By Company 2018

7. Market Dynamics

7.1. Growth Drivers & Barriers in Opioids Agonist Drugs Market
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Rest of World
7.2. Opportunities in Opioids Agonist Drugs Market

8. Global Opioids Agonist Drugs Market

8.1. Introduction
8.2. Key Trends & Growth Drivers
8.3. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

9. Global Opioids Agonist Drugs Market Segmentation Analysis, By Product Type

9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Product Type
9.2.2. Market Attractiveness, By Product Type
9.3. Codeine
9.3.1. Key Trends & Growth Drivers
9.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Fentanyl
9.4.1. Key Trends & Growth Drivers
9.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5. Meperidine
9.5.1. Key Trends & Growth Drivers
9.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6. Methadone
9.6.1. Key Trends & Growth Drivers
9.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.7. Morphine
9.7.1. Key Trends & Growth Drivers
9.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.8. Hydrocodone
9.8.1. Key Trends & Growth Drivers
9.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

10. Global Opioids Agonist Drugs Market Segmentation Analysis, By Therapeutic Application

10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Therapeutic Application
10.2.2. Market Attractiveness, By Therapeutic Application
10.3. Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, Others)
10.3.1. Key Trends & Growth Drivers
10.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4. Cough Treatment
10.4.1. Key Trends & Growth Drivers
10.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5. Diarrhea Treatment
10.5.1. Key Trends & Growth Drivers
10.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11. Geographical Analysis

11.1. Introduction
11.2. North America Opioids Agonist Drugs Market
11.2.1. Key Trends & Growth Drivers
11.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4. By Product Type
11.2.4.1. Introduction
11.2.4.2. Strategic Insights
11.2.4.2.1. BPS Analysis, By Product Type
11.2.4.2.2. Market Attractiveness, By Product Type
11.2.4.3. Codeine
11.2.4.3.1. Key Trends & Growth Drivers
11.2.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.4. Fentanyl
11.2.4.4.1. Key Trends & Growth Drivers
11.2.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.5. Meperidine
11.2.4.5.1. Key Trends & Growth Drivers
11.2.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.6. Methadone
11.2.4.6.1. Key Trends & Growth Drivers
11.2.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.7. Morphine
11.2.4.7.1. Key Trends & Growth Drivers
11.2.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.8. Hydrocodone
11.2.4.8.1. Key Trends & Growth Drivers
11.2.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5. By Therapeutic Application
11.2.5.1. Introduction
11.2.5.2. Strategic Insights
11.2.5.2.1. BPS Analysis, By Therapeutic Application
11.2.5.2.2. Market Attractiveness, By Therapeutic Application
11.2.5.3. Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, Others)
11.2.5.3.1. Key Trends & Growth Drivers
11.2.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.4. Cough Treatment
11.2.5.4.1. Key Trends & Growth Drivers
11.2.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.5. Diarrhea Treatment
11.2.5.5.1. Key Trends & Growth Drivers
11.2.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6. By Country
11.2.6.1. Introduction
11.2.6.2. Strategic Insights
11.2.6.2.1. BPS Analysis, By Country
11.2.6.2.2. Market Attractiveness, By Country
11.2.6.3. U.S. Opioids Agonist Drugs Market
11.2.6.3.1. Key Trends & Growth Drivers
11.2.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6.4. Canada Opioids Agonist Drugs Market
11.2.6.4.1. Key Trends & Growth Drivers
11.2.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.3. Europe Opioids Agonist Drugs Market
11.3.1. Key Trends & Growth Drivers
11.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4. By Product Type
11.3.4.1. Introduction
11.3.4.2. Strategic Insights
11.3.4.2.1. BPS Analysis, By Product Type
11.3.4.2.2. Market Attractiveness, By Product Type
11.3.4.3. Codeine
11.3.4.3.1. Key Trends & Growth Drivers
11.3.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.4. Fentanyl
11.3.4.4.1. Key Trends & Growth Drivers
11.3.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.5. Meperidine
11.3.4.5.1. Key Trends & Growth Drivers
11.3.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.6. Methadone
11.3.4.6.1. Key Trends & Growth Drivers
11.3.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.7. Morphine
11.3.4.7.1. Key Trends & Growth Drivers
11.3.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.8. Hydrocodone
11.3.4.8.1. Key Trends & Growth Drivers
11.3.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5. By Therapeutic Application
11.3.5.1. Introduction
11.3.5.2. Strategic Insights
11.3.5.2.1. BPS Analysis, By Therapeutic Application
11.3.5.2.2. Market Attractiveness, By Therapeutic Application
11.3.5.3. Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, Others)
11.3.5.3.1. Key Trends & Growth Drivers
11.3.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.4. Cough Treatment
11.3.5.4.1. Key Trends & Growth Drivers
11.3.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.5. Diarrhea Treatment
11.3.5.5.1. Key Trends & Growth Drivers
11.3.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6. By Country
11.3.6.1. Introduction
11.3.6.2. Strategic Insights
11.3.6.2.1. BPS Analysis, By Country
11.3.6.2.2. Market Attractiveness, By Country
11.3.6.3. Germany Opioids Agonist Drugs Market
11.3.6.3.1. Key Trends & Growth Drivers
11.3.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.4. United Kingdom Opioids Agonist Drugs Market
11.3.6.4.1. Key Trends & Growth Drivers
11.3.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.5. France Opioids Agonist Drugs Market
11.3.6.5.1. Key Trends & Growth Drivers
11.3.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.6. Italy Opioids Agonist Drugs Market
11.3.6.6.1. Key Trends & Growth Drivers
11.3.6.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.7. Spain Opioids Agonist Drugs Market
11.3.6.7.1. Key Trends & Growth Drivers
11.3.6.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.8. Russia Opioids Agonist Drugs Market
11.3.6.8.1. Key Trends & Growth Drivers
11.3.6.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.9. Rest of Europe Opioids Agonist Drugs Market
11.3.6.9.1. Key Trends & Growth Drivers
11.3.6.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.4. Asia Pacific Opioids Agonist Drugs Market
11.4.1. Key Trends & Growth Drivers
11.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4. By Product Type
11.4.4.1. Introduction
11.4.4.2. Strategic Insights
11.4.4.2.1. BPS Analysis, By Product Type
11.4.4.2.2. Market Attractiveness, By Product Type
11.4.4.3. Codeine
11.4.4.3.1. Key Trends & Growth Drivers
11.4.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.4. Fentanyl
11.4.4.4.1. Key Trends & Growth Drivers
11.4.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.5. Meperidine
11.4.4.5.1. Key Trends & Growth Drivers
11.4.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.6. Methadone
11.4.4.6.1. Key Trends & Growth Drivers
11.4.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.7. Morphine
11.4.4.7.1. Key Trends & Growth Drivers
11.4.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.8. Hydrocodone
11.4.4.8.1. Key Trends & Growth Drivers
11.4.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5. By Therapeutic Application
11.4.5.1. Introduction
11.4.5.2. Strategic Insights
11.4.5.2.1. BPS Analysis, By Therapeutic Application
11.4.5.2.2. Market Attractiveness, By Therapeutic Application
11.4.5.3. Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, Others)
11.4.5.3.1. Key Trends & Growth Drivers
11.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.4. Cough Treatment
11.4.5.4.1. Key Trends & Growth Drivers
11.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.5. Diarrhea Treatment
11.4.5.5.1. Key Trends & Growth Drivers
11.4.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6. By Country
11.4.6.1. Introduction
11.4.6.2. Strategic Insights
11.4.6.2.1. BPS Analysis, By Country
11.4.6.2.2. Market Attractiveness, By Country
11.4.6.3. China Opioids Agonist Drugs Market
11.4.6.3.1. Key Trends & Growth Drivers
11.4.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.4. India Opioids Agonist Drugs Market
11.4.6.4.1. Key Trends & Growth Drivers
11.4.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.5. Japan Opioids Agonist Drugs Market
11.4.6.5.1. Key Trends & Growth Drivers
11.4.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.6. South Korea Opioids Agonist Drugs Market
11.4.6.6.1. Key Trends & Growth Drivers
11.4.6.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.7. Indonesia Opioids Agonist Drugs Market
11.4.6.7.1. Key Trends & Growth Drivers
11.4.6.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.8. Taiwan Opioids Agonist Drugs Market
11.4.6.8.1. Key Trends & Growth Drivers
11.4.6.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.9. Australia Opioids Agonist Drugs Market
11.4.6.9.1. Key Trends & Growth Drivers
11.4.6.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.10. New Zealand Opioids Agonist Drugs Market
11.4.6.10.1. Key Trends & Growth Drivers
11.4.6.10.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.10.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.11. Rest of Asia Pacific Opioids Agonist Drugs Market
11.4.6.11.1. Key Trends & Growth Drivers
11.4.6.11.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.11.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.5. Latin America Opioids Agonist Drugs Market
11.5.1. Key Trends & Growth Drivers
11.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4. By Product Type
11.5.4.1. Introduction
11.5.4.2. Strategic Insights
11.5.4.2.1. BPS Analysis, By Product Type
11.5.4.2.2. Market Attractiveness, By Product Type
11.5.4.3. Codeine
11.5.4.3.1. Key Trends & Growth Drivers
11.5.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.4. Fentanyl
11.5.4.4.1. Key Trends & Growth Drivers
11.5.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.5. Meperidine
11.5.4.5.1. Key Trends & Growth Drivers
11.5.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.6. Methadone
11.5.4.6.1. Key Trends & Growth Drivers
11.5.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.7. Morphine
11.5.4.7.1. Key Trends & Growth Drivers
11.5.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.8. Hydrocodone
11.5.4.8.1. Key Trends & Growth Drivers
11.5.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5. By Therapeutic Application
11.5.5.1. Introduction
11.5.5.2. Strategic Insights
11.5.5.2.1. BPS Analysis, By Therapeutic Application
11.5.5.2.2. Market Attractiveness, By Therapeutic Application
11.5.5.3. Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, Others)
11.5.5.3.1. Key Trends & Growth Drivers
11.5.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.4. Cough Treatment
11.5.5.4.1. Key Trends & Growth Drivers
11.5.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.5. Diarrhea Treatment
11.5.5.5.1. Key Trends & Growth Drivers
11.5.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6. By Country
11.5.6.1. Introduction
11.5.6.2. Strategic Insights
11.5.6.2.1. BPS Analysis, By Country
11.5.6.2.2. Market Attractiveness, By Country
11.5.6.3. Brazil Opioids Agonist Drugs Market
11.5.6.3.1. Key Trends & Growth Drivers
11.5.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.4. Mexico Opioids Agonist Drugs Market
11.5.6.4.1. Key Trends & Growth Drivers
11.5.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.5. Rest of Latin America Opioids Agonist Drugs Market
11.5.6.5.1. Key Trends & Growth Drivers
11.5.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.6. Middle East & Africa Opioids Agonist Drugs Market
11.6.1. Key Trends & Growth Drivers
11.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4. By Product Type
11.6.4.1. Introduction
11.6.4.2. Strategic Insights
11.6.4.2.1. BPS Analysis, By Product Type
11.6.4.2.2. Market Attractiveness, By Product Type
11.6.4.3. Codeine
11.6.4.3.1. Key Trends & Growth Drivers
11.6.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.4. Fentanyl
11.6.4.4.1. Key Trends & Growth Drivers
11.6.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.5. Meperidine
11.6.4.5.1. Key Trends & Growth Drivers
11.6.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.6. Methadone
11.6.4.6.1. Key Trends & Growth Drivers
11.6.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.7. Morphine
11.6.4.7.1. Key Trends & Growth Drivers
11.6.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.8. Hydrocodone
11.6.4.8.1. Key Trends & Growth Drivers
11.6.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5. By Therapeutic Application
11.6.5.1. Introduction
11.6.5.2. Strategic Insights
11.6.5.2.1. BPS Analysis, By Therapeutic Application
11.6.5.2.2. Market Attractiveness, By Therapeutic Application
11.6.5.3. Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, Others)
11.6.5.3.1. Key Trends & Growth Drivers
11.6.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.4. Cough Treatment
11.6.5.4.1. Key Trends & Growth Drivers
11.6.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.5. Diarrhea Treatment
11.6.5.5.1. Key Trends & Growth Drivers
11.6.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6. By Geography
11.6.6.1. Introduction
11.6.6.2. Strategic Insights
11.6.6.2.1. BPS Analysis, By Geography
11.6.6.2.2. Market Attractiveness, By Geography
11.6.6.3. GCC Opioids Agonist Drugs Market
11.6.6.3.1. Key Trends & Growth Drivers
11.6.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.4. North Africa Opioids Agonist Drugs Market
11.6.6.4.1. Key Trends & Growth Drivers
11.6.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.5. South Africa Opioids Agonist Drugs Market
11.6.6.5.1. Key Trends & Growth Drivers
11.6.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.6. Rest of Middle East & Africa Opioids Agonist Drugs Market
11.6.6.6.1. Key Trends & Growth Drivers
11.6.6.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12. Company Profile
12.1. Market Share of Key Players in Opioids Agonist Drugs Market
12.2. Opioids Agonist Drugs Company Analysis
12.2.1. Pfizer, Inc.
12.2.1.1. Company Overview
12.2.1.2. Product Offered
12.2.1.3. Business Strategy
12.2.1.4. Financials
12.2.1.5. SWOT Analysis
12.2.1.6. Market Share Analysis
12.2.1.7. Key Achievements & Developments
12.2.2. Purdue Pharma
12.2.2.1. Company Overview
12.2.2.2. Product Offered
12.2.2.3. Business Strategy
12.2.2.4. Financials
12.2.2.5. SWOT Analysis
12.2.2.6. Market Share Analysis
12.2.2.7. Key Achievements & Developments
12.2.3. Titan pharmaceuticals
12.2.3.1. Company Overview
12.2.3.2. Product Offered
12.2.3.3. Business Strategy
12.2.3.4. Financials
12.2.3.5. SWOT Analysis
12.2.3.6. Market Share Analysis
12.2.3.7. Key Achievements & Developments
12.2.4. Allergan plc
12.2.4.1. Company Overview
12.2.4.2. Product Offered
12.2.4.3. Business Strategy
12.2.4.4. Financials
12.2.4.5. SWOT Analysis
12.2.4.6. Market Share Analysis
12.2.4.7. Key Achievements & Developments
12.2.5. Boehringer Ingelheim
12.2.5.1. Company Overview
12.2.5.2. Product Offered
12.2.5.3. Business Strategy
12.2.5.4. Financials
12.2.5.5. SWOT Analysis
12.2.5.6. Market Share Analysis
12.2.5.7. Key Achievements & Developments
12.2.6. Merck & Co., Inc.
12.2.6.1. Company Overview
12.2.6.2. Product Offered
12.2.6.3. Business Strategy
12.2.6.4. Financials
12.2.6.5. SWOT Analysis
12.2.6.6. Market Share Analysis
12.2.6.7. Key Achievements & Developments
12.2.7. Janssen Pharmaceuticals, Inc.
12.2.7.1. Company Overview
12.2.7.2. Product Offered
12.2.7.3. Business Strategy
12.2.7.4. Financials
12.2.7.5. SWOT Analysis
12.2.7.6. Market Share Analysis
12.2.7.7. Key Achievements & Developments
12.2.8. Sanofi
12.2.8.1. Company Overview
12.2.8.2. Product Offered
12.2.8.3. Business Strategy
12.2.8.4. Financials
12.2.8.5. SWOT Analysis
12.2.8.6. Market Share Analysis
12.2.8.7. Key Achievements & Developments
12.2.9. Sun Pharmaceuticals
12.2.9.1. Company Overview
12.2.9.2. Product Offered
12.2.9.3. Business Strategy
12.2.9.4. Financials
12.2.9.5. SWOT Analysis
12.2.9.6. Market Share Analysis
12.2.9.7. Key Achievements & Developments
12.2.10. Mallinckrodt Pharmaceuticals
12.2.10.1. Company Overview
12.2.10.2. Product Offered
12.2.10.3. Business Strategy
12.2.10.4. Financials
12.2.10.5. SWOT Analysis
12.2.10.6. Market Share Analysis
12.2.10.7. Key Achievements & Developments
12.2.11. Egalet Corporation
12.2.11.1. Company Overview
12.2.11.2. Product Offered
12.2.11.3. Business Strategy
12.2.11.4. Financials
12.2.11.5. SWOT Analysis
12.2.11.6. Market Share Analysis
12.2.11.7. Key Achievements & Developments
12.2.12. Endo Pharmaceuticals Inc.
12.2.12.1. Company Overview
12.2.12.2. Product Offered
12.2.12.3. Business Strategy
12.2.12.4. Financials
12.2.12.5. SWOT Analysis
12.2.12.6. Market Share Analysis
12.2.12.7. Key Achievements & Developments
12.2.13. Other Prominent Players

13. Disclaimer

Select License Type
  • Single User License $3750 USD
  • Multi-User License $4750 USD
  • Corporate User License $5750 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients